Share This Page
Drug Price Trends for SUBVENITE
✉ Email this page to a colleague

Average Pharmacy Cost for SUBVENITE
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
SUBVENITE 25 MG TABLET | 69102-0301-01 | 0.02750 | EACH | 2025-01-22 |
SUBVENITE 100 MG TABLET | 69102-0319-01 | 0.04060 | EACH | 2025-01-22 |
SUBVENITE TAB START KT(ORANGE) | 69102-0300-01 | 14.39490 | EACH | 2025-01-22 |
SUBVENITE 150 MG TABLET | 69102-0150-06 | 0.05997 | EACH | 2025-01-22 |
SUBVENITE 200 MG TABLET | 69102-0320-01 | 0.07339 | EACH | 2025-01-22 |
SUBVENITE 25 MG TABLET | 69102-0301-01 | 0.02741 | EACH | 2024-12-18 |
SUBVENITE 100 MG TABLET | 69102-0319-01 | 0.04236 | EACH | 2024-12-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for SUBVENITE (Lamotrigine)
Overview of SUBVENITE
SUBVENITE, also known as lamotrigine, is an antiepileptic drug used in the treatment of epilepsy and as a mood stabilizer for bipolar disorder. It is indicated for adjunctive therapy in patients aged 2 years and older with various types of seizures, and for the maintenance treatment of bipolar I disorder in adults[1][3][5].
Market Demand and Usage
Clinical Indications
SUBVENITE is widely used for several clinical indications, including:
- Adjunctive therapy for partial seizures, primary generalized tonic-clonic seizures, and generalized seizures due to Lennox-Gastaut syndrome in patients aged 2 years and older.
- Monotherapy conversion for patients aged 16 years and older with partial-onset seizures.
- Maintenance treatment of bipolar I disorder to delay the occurrence of mood episodes in adults[1][3][5].
The diverse range of indications contributes to a steady and significant demand for the drug.
Pricing and Cost Considerations
Current Pricing
The cost of SUBVENITE varies based on the dosage and the pharmacy. Here are some current price points:
- 25 mg oral tablet: Around $108 for a supply of 100 tablets.
- 100 mg oral tablet: Around $143.51 for a supply of 100 tablets.
- 150 mg oral tablet: Around $149.88 for a supply of 100 tablets.
- 200 mg oral tablet: Around $164.89 for a supply of 100 tablets[2].
Generic Alternatives
A generic version of lamotrigine is available, significantly reducing the cost. For example, generic lamotrigine can cost as low as $26.80 for 100 tablets of the 25 mg dosage[2].
Coupons, Copay Cards, and Patient Assistance
To make the drug more accessible, various coupons, copay cards, and patient assistance programs are available. These can significantly reduce the out-of-pocket costs for patients[2].
Market Trends and Projections
Drug Price Inflation
According to Vizient's summer Pharmacy Market Outlook, the overall drug price inflation rate for pharmaceuticals is projected to be 3.81% in 2025. This trend suggests that prices for SUBVENITE and other medications may increase, although the specific impact on SUBVENITE is not detailed in the report[4].
Impact of Generic Competition
The availability of generic lamotrigine has a significant impact on the pricing of SUBVENITE. Generic competition typically drives down the prices of brand-name drugs, making them more competitive in the market. This trend is likely to continue, influencing the pricing strategy for SUBVENITE[2].
Expanding Indications and Market Growth
While SUBVENITE's indications are well-established, the broader trend of expanding indications for other medications (such as GLP-1 agents) could indirectly influence market dynamics. However, SUBVENITE's specific market growth will be more directly tied to its established use cases and the presence of generic alternatives[4].
Patient and Provider Perspectives
Patient Access and Affordability
Patient access to SUBVENITE is crucial, and affordability is a significant factor. The availability of savings cards, copay cards, and patient assistance programs helps make the drug more accessible. However, the ongoing price inflation in the pharmaceutical market could pose challenges for patients in the future[2].
Provider Considerations
Healthcare providers need to balance the therapeutic benefits of SUBVENITE with its cost implications. Given the drug's efficacy and the availability of generic options, providers often opt for the more affordable generic version to manage patient care costs effectively[2][3].
Regulatory and Safety Considerations
Safety Warnings
SUBVENITE carries serious safety warnings, including the risk of life-threatening skin rashes such as Stevens-Johnson syndrome and toxic epidermal necrolysis. These warnings are critical for both patients and healthcare providers to consider when prescribing and using the drug[1].
Contraindications and Precautions
The drug is contraindicated in patients with hypersensitivity to lamotrigine or its ingredients. Additionally, there are specific dosing guidelines and considerations to prevent adverse reactions, which healthcare providers must carefully follow[1][3].
Key Takeaways
- Market Demand: SUBVENITE has a steady demand due to its multiple clinical indications.
- Pricing: The drug's cost varies, but generic alternatives significantly reduce the price.
- Market Trends: Drug price inflation and generic competition are key factors influencing the market.
- Patient and Provider Perspectives: Affordability and therapeutic benefits are crucial considerations.
- Regulatory and Safety Considerations: Serious safety warnings and contraindications must be carefully managed.
FAQs
What are the primary uses of SUBVENITE?
SUBVENITE is used as adjunctive therapy for various types of seizures and as a mood stabilizer for bipolar I disorder[1][3][5].
How much does SUBVENITE cost?
The cost of SUBVENITE varies by dosage, but a supply of 100 tablets of the 25 mg dosage can cost around $108. Generic versions are significantly cheaper, starting at $26.80 for 100 tablets[2].
Are there any serious safety warnings associated with SUBVENITE?
Yes, SUBVENITE carries warnings for life-threatening skin rashes such as Stevens-Johnson syndrome and toxic epidermal necrolysis. It should be discontinued at the first sign of rash unless clearly not drug-related[1].
What are the contraindications for SUBVENITE?
SUBVENITE is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients[1].
How does the availability of generic lamotrigine affect the market for SUBVENITE?
The availability of generic lamotrigine significantly reduces the cost and makes the drug more competitive, influencing the pricing strategy for SUBVENITE[2].
Sources
- Subvenite Starter Kits - Subvenite Starter Kits help simplify treatment initiation for you and your patients in a more structured way than is offered by multiple weekly prescriptions. [Subvenite]
- Subvenite Prices, Coupons, Copay Cards & Patient Assistance - The cost for Subvenite 25 mg oral tablet is around $108 for a supply of 100 tablets. [Drugs.com]
- Lamotrigine: Uses, Interactions, Mechanism of Action - Lamotrigine is an antiepileptic drug belonging to the phenyltriazine class. [DrugBank]
- Vizient projects drug price inflation at 3.81% - Vizient, Inc. released its summer Pharmacy Market Outlook estimating the 2025 overall drug price inflation rate for pharmaceuticals at 3.81%. [Vizient]
- Subvenite Oral: Uses, Side Effects, Interactions, Pictures, Warnings - Lamotrigine is used alone or with other medications to prevent and control seizures. [WebMD]
More… ↓